PP-34
|
EMİNE EYLEM
|
GENÇ
|
LANGERHANS CELL HISTIOCYTOSIS IN ADULTS: CLINIC PRESENTATION,
TREATMENT OPTIONS AND PROGNOSIS
|
PP-35
|
NUR
|
SOYER
|
RETROSPECTIVE AND MULTICENTER ANALYSIS OF EFFICACY AND SAFETY
OF RUXOLITINIB IN 176 TURKISH PATIENTS WITH MYELOFIBROSIS:
UPDATED DATA
|
PP-36
|
ÖMER
|
EKİNCİ
|
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH ACUTE
HEPATITIS A DISEASE
|
PP-37
|
MEHMET
|
BANKİR
|
CLINICAL AND LABORATORY PARAMETERS OF JAK2V617F MUTATION IN
ESSENTIAL THROMBOCYTOSIS PATIENTS
|
PP-38
|
ÖMER
|
EKİNCİ
|
ACQUIRED VON WILLEBRAND DISEASE IN CHRONIC MYELOPROLIFERATIVE
DISORDERS
|
PP-39
|
AYSUN
|
ŞENTÜRK YIKILMAZ
|
THIOL– DISULPHIDE HOMEOSTASIS IN ESSENTIAL THROMBOCYTEMIA
PATIENTS
|
PP-40
|
MUFİDE
|
OKAY
|
DESCRIPTIVE ANALYSIS OF MYELOPROLIFERATIVE DISEASES AND ITS
COMPLICATIONS
|
PP-41
|
RAFİYE
|
CİFTCİLER
|
HIV INFECTION RELATED HAEMATOLOGIC NEOPLASTIC DISEASES
|
PP-42
|
ENİSA
|
ZARİC
|
PREGNANCY OUTCOMES IN A CASE OF PROTEIN S DEFICIENCY CARRIERS
COUPLE
|
PP-43
|
SİNAN
|
DEMİRCİOĞLU
|
A RARE CAUSE OF PANCYTOPENIA: TRANSFUSION- ASSOCIATED GRAFT
VERSUS HOST DISEASE
|
PP-44
|
PINAR
|
CÖMERT
|
REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA IN A PATIENT
WITH KAPOSI SARCOMA
|
PP-45
|
ÖMER
|
EKİNCİ
|
DECREASED BONE MINERAL DENSITY AND RELATED PARAMETERS IN SEVERE
HEMOPHILIA A PATIENTS: A CASE-CONTROL STUDY
|
PP-46
|
PINAR
|
ÇAKAN
|
IL-1BETA, IL-6 AND TNF-ALPHA LEVELS IN WOMEN WORKING UNDER
LONG-TERM (32-36 H) SHIFTS
|
PP-47
|
GHADA
|
ELGOHARY
|
VITAMIN D INSUFFICIENCY IN NON HODGKIN LYMPHOMA AND ITS
RELATION TO ADVERSE PROGNOSTIC FACTORS: A SINGLE CENTER
ANALYSIS
|
PP-48
|
ISABELLA
|
LO
|
THE SAFETY AND EFFICACY OF THE BIOSIMILAR ANTI-CD20 ANTIBODY,
TRUXIMA, IN HEAMATOLOGICAL MALIGNANCY
|
PP-49
|
MÜRÜVVET SEDA
|
AYDIN
|
CAUSES OF THROMBOSIS IN HODGKIN LYMPHOMA: SINGLE CENTER
EXPERIENCE
|
PP-50
|
MÜRÜVVET SEDA
|
AYDIN
|
BRENTUXIMAB VEDOTIN IN CD30+ LYMPHOMAS: SINGLE CENTER
EXPERIENCE
|
PP-51
|
EMRAH
|
KILIÇASLAN
|
A MYCOSIS FUNGOIDES CASE; TWO MONTH LATER AFTER HODGKIN
LYMPHOMA TREATMENT
|
PP-52
|
ÖMER
|
EKİNCİ
|
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF NON-HODGKIN
LYMPHOMA PATIENTS IN EASTERN OF TURKEY: A SINGLE-CENTER STUDY
|
PP-53
|
SENEM
|
MARAL
|
A RARE PRESENTATION: LUNG ADENOCARCINOMA FOLLOWING BONE MARROW
TRANSPLANTATION FOR MANTLE CELL LYMPHOMA
|
PP-54
|
AYŞE
|
UYSAL
|
AN ATYPICAL PRESENTATION:FOLLICULAR LYMPHOMA WITH PERIPHERAL
BLOOD INVOLVEMENT
|
PP-55
|
OSMAN
|
ŞAHİN
|
LYMPHOMATOID PAPULOSIS AFTER AUTOLOGOUS STEM CEL
TRANSPLANTATION IN A PATIENT WITH DIFFUSE LARGE B CELL LYMPHOMA
|
PP-56
|
AYSUN
|
GÖNDEREN
|
A RARE CASE REPORT OF PRIMARY BONE LYMPHOMA
|
PP-57
|
DENİZ
|
TUĞCU
|
HOW CAN WE TREAT HODGKIN LYMPHOMA DEVELOPED AFTER HEMATOPOIETIC
STEM CELL TRANSPLANTATION DUE TO IL10R DEFICIENCY, CROHN
DISEASE AND EBV INFECTİON?
|
PP-58
|
BİRGÜL
|
ÖNEÇ
|
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ASSOCIATED RAYNAUD
PHENOMENON AND DIGITAL NECROSIS
|
PP-59
|
BİRGÜL
|
ÖNEÇ
|
HODGKIN LYMPHOMA PRESENTED WITH MASSIVE PLEURAL EFFUSION
|
PP-60
|
EMİN
|
ABDULLAYEV
|
CASE REPORT: CARDIAC AMYLOIDOSIS.
|
PP-61
|
ATAKAN
|
TURGUTKAYA
|
INCREASE OF CD33 EXPRESSION IN MULTIPLE MYELOMA ESTIMATES SHORT
SURVIVAL
|
PP-62
|
ÜMİT YAVUZ
|
MALKAN
|
LENALIDOMIDE PROVIDE BETTER PROGRESSION FREE SURVIVAL THAN
THALIDOMIDE AND BORTEZOMIB IN THE FIRST RELAPSE OF MULTIPLE
MYELOMA PATIENTS AFTER AUTOLOGOUS TRANSPLANTATION
|
PP-63
|
YUSUF
|
ULUSOY
|
CLINICAL FEATURES AND OUTCOMES OF SOLITARY PLASMACYTOMAS:
SINGLE-CENTER EXPERIENCE FROM TURKEY
|
PP-64
|
ESRA
|
KILIÇ
|
INVESTIGATION OF B-LYMPHOCYTE F-ACTIN CELL SKELETON IN MULTIPLE
MYELOMA PATIENTS
|
PP-65
|
ALİ ZAHİT
|
BOLAMAN
|
THE ENGRAFTMENT DETERMINANTS AT AUTOLOGOUS STEM CELL
TRANSPLANTATION IN PATIENTS WITH MYELOMA
|
PP-66
|
HALE
|
BÜLBÜL
|
SUCCESFUL TREATMENT OF PATIENTS WITH AML AND MDS BY DECITABINE;
SINGLE CENTRE EXPERIENCE
|
PP-67
|
ŞERİFE
|
SOLMAZ
|
GRANULOCYTIC SARCOMA WITH UNUSUAL LOCALIZATIONS (BREAST AND
STOMACH) WITHOUT BONE MARROW INVOLVEMENT AFTER ALLOGENEIC
TRANSPLANTATION
|